Linked Life Data

18928937

Source:http://linkedlifedata.com/resource/pubmed/id/18928937

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2008-10-20
pubmed:abstractText
Annual testing for fecal occult blood is recommended as first-line screening for the detection of colorectal cancer (CRC), but is affected by limited sensitivity. We initiated a proteomics-based search for novel biomarkers to improve the sensitivity of detection of CRC in stool samples.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1542-7714
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1122-8
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
pubmed:affiliation
Department of New Technologies, Professional Diagnostics, Roche Diagnostics GmbH, Penzberg, Germany. johann.karl@roche.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies